Efficacy and safety of non‐vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta‐analysis of controlled randomized trials

Documenti analoghi

• Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure
  di: Lo‐Chieh Ling, et al.
  Pubblicazione: (2024)
• Long‐term outcome of lesion size index‐guided high‐power ablation with high‐density mapping for pulmonary vein isolation in patients with paroxysmal atrial fibrillation
  di: Ming‐Jen Kuo, et al.
  Pubblicazione: (2025)
• Intravenous thrombolysis following dabigatran reversal in a patient with acute embolic stroke after atrial fibrillation ablation
  di: Yi‐Sheng Chen, et al.
  Pubblicazione: (2024)
• Impact of left ventricular diastolic function and direct oral anticoagulant use for predicting embolic events in patients with heart failure and atrial fibrillation
  di: Jumpei Yamamoto, et al.
  Pubblicazione: (2024)
• Number needed to treat for net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation
  di: Rungroj Krittayaphong, et al.
  Pubblicazione: (2025)